ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 797,58
-1,92%
Dow Jones
44 544,66
-0,75%
DAX
21 295,97
-1,91%
Brent Oil
76,62
0,35%
Bitcoin
95 265,75
-2,49%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Hutchmed (china) Limited (HCM)

  7. Hutchmed (china) Limited (HCM) Actualités

HCM

Hutchmed (china) (HCM)

Hutchmed (china) Limited
De:
Trier par:
 Showing the most relevant articles for your search:LSE:HCM
DateHeureSourceTitreSymboleSociété
28/01/202510h00RNS Regulatory NewsHutchmed (China) Limited Overseas Regulatory AnnouncementLSE:HCMHutchmed (china) Limited
14/01/202513h07Alliance NewsAlliance NewsIN BRIEF: Hutchmed lung cancer treatment Orpathys approved in ChinaLSE:HCMHutchmed (china) Limited
14/01/202508h00RNS Non-RegulatoryHutchmed (China) Limited Full Approval for ORPATHYS in ChinaLSE:HCMHutchmed (china) Limited
02/01/202511h46Alliance NewsAlliance NewsHutchmed China disposes of 45% stake in Shanghai joint ventureLSE:HCMHutchmed (china) Limited
02/01/202508h01RNS Non-RegulatoryHutchmed (China) Limited China NDA Acceptance for ORPATHYS and TAGRISSOLSE:HCMHutchmed (china) Limited
02/01/202508h00RNS Regulatory NewsHutchmed (China) Limited US$608m Divestment of Non-Core Joint VentureLSE:HCMHutchmed (china) Limited
31/12/202409h30RNS Regulatory NewsHutchmed (China) Limited Appointment of Joint Corporate BrokerLSE:HCMHutchmed (china) Limited
30/12/202409h30RNS Regulatory NewsHutchmed (China) Limited Blocklisting Six Monthly ReturnLSE:HCMHutchmed (china) Limited
13/12/202411h04Alliance NewsAlliance NewsIN BRIEF: Hutchmed to get Takeda milestone paymentLSE:HCMHutchmed (china) Limited
13/12/202408h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED to Receive Milestone Payment from TakedaLSE:HCMHutchmed (china) Limited
12/12/202408h00RNS Non-RegulatoryHutchmed (China) Limited Breakthrough Therapy Designation in ChinaLSE:HCMHutchmed (china) Limited
03/12/202413h19Alliance NewsAlliance NewsHutchmed China injection approval could be a "paradigm shift"LSE:HCMHutchmed (china) Limited
03/12/202411h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED and Innovent Announce ELUNATE ApprovalLSE:HCMHutchmed (china) Limited
29/11/202409h30RNS Regulatory NewsHutchmed (China) Limited Total Voting RightsLSE:HCMHutchmed (china) Limited
28/11/202411h32RNS Non-RegulatoryHutchmed (China) Limited Continued Inclusion of ORPATHYS in China NRDLLSE:HCMHutchmed (china) Limited
22/11/202411h00Alliance NewsAlliance NewsHutchmed to get payment from Takeda as Fruzaqla launched in JapanLSE:HCMHutchmed (china) Limited
22/11/202408h00RNS Non-RegulatoryHutchmed (China) Limited FRUZAQLA® Launched in Japan by TakedaLSE:HCMHutchmed (china) Limited
20/11/202410h30RNS Regulatory NewsHutchmed (China) Limited Appointment of Independent Non-executive DirectorLSE:HCMHutchmed (china) Limited
06/11/202408h00RNS Non-RegulatoryHutchmed (China) Limited Clinical Data to be Presented at ASH and ESMO AsiaLSE:HCMHutchmed (china) Limited
31/10/202413h02Alliance NewsAlliance NewsHutchmed China receives first milestone payment for Takeda drug salesLSE:HCMHutchmed (china) Limited
31/10/202409h30RNS Non-RegulatoryHutchmed (China) Limited First Commercial Milestone PaymentLSE:HCMHutchmed (china) Limited
21/10/202410h30RNS Regulatory NewsHutchmed (China) Limited Vesting of awards under the LTIPLSE:HCMHutchmed (china) Limited
16/10/202410h52Alliance NewsAlliance NewsTOP NEWS: AstraZeneca's Tagrisso plus Orpathys shows promising resultsLSE:HCMHutchmed (china) Limited
16/10/202408h00RNS Regulatory NewsHutchmed (China) Limited SAVANNAH: clinically meaningful response rateLSE:HCMHutchmed (china) Limited
24/09/202409h49Alliance NewsAlliance NewsTakeda Pharmaceutical says Fruzaqla cancer drug gets Japan backingLSE:HCMHutchmed (china) Limited
24/09/202409h00RNS Regulatory NewsHutchmed (China) Limited Japan Approval for FRUZAQLALSE:HCMHutchmed (china) Limited
09/09/202408h00RNS Non-RegulatoryHutchmed (China) Limited Clinical Data to be Presented at ESMO and WCLCLSE:HCMHutchmed (china) Limited
30/08/202413h24Alliance NewsAlliance NewsHutchmed "disappointed" as it withdraws fruquintinib applicationLSE:HCMHutchmed (china) Limited
30/08/202408h00RNS Regulatory NewsHutchmed (China) Limited Update on Fruquintinib for Gastric Cancer in ChinaLSE:HCMHutchmed (china) Limited
22/08/202410h30RNS Regulatory NewsHutchmed (China) Limited Standard form for notification of major holdingsLSE:HCMHutchmed (china) Limited
 Showing the most relevant articles for your search:LSE:HCM

Dernières Valeurs Consultées

GATE
ABTUSDT
ArcBlock
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces